Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-022063
Filing Date
2025-08-04
Accepted
2025-08-04 16:45:06
Documents
1
Period of Report
2025-07-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 9384
  Complete submission text file 0001641172-25-022063.txt   12153
Mailing Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022 2128473500
GOLDENTREE ASSET MANAGEMENT LP (Reporting) CIK: 0001278951 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 251181049

Mailing Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address
Tananbaum Steven A. (Reporting) CIK: 0001435626 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 251181047

Mailing Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022 212-847-3500
GoldenTree Asset Management LLC (Reporting) CIK: 0001435627 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 251181048

Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15 353 1 6960000
Mallinckrodt plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | State of Incorp.: L2 | Fiscal Year End: 1226
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)